Relative efficacy and interchangeability of various clobetasol propionate vehicles in the management of steroid-responsive dermatoses

Current Therapeutic Research - Clinical and Experimental

Volumn 66, Issue 3, 2005, Pages 154-171

  Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Anti inflammatory; Atopic dermatitis; Class I agents; Clobetasol propionate; Cosmetic acceptability; Duration of response; Efficacy; Plaque type psoriasis; Potency; Safety; Topical corticosteroids; Vasoconstriction; Vehicle

Indexed keywords

ALCLOMETASONE DIPROPIONATE; BETAMETHASONE DIPROPIONATE; BETAMETHASONE VALERATE; CALCIPOTRIOL; CLOBETASOL PROPIONATE; CLOBEX; CORTICOSTEROID; DESONIDE; DIFLORASONE DIACETATE; DRUG VEHICLE; EMOLLIENT AGENT; FLUTICASONE PROPIONATE; HALCINONIDE; HYDROCORTISONE BUTYRATE; MOMETASONE FUROATE; PSORCON E; STEROID; TEMOVATE E; ULOBETASOL PROPIONATE;

ATOPIC DERMATITIS; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG PENETRATION; DRUG POTENCY; DRUG TOLERABILITY; DRY SKIN; GRANULOMA ANNULARE; HUMAN; INSECT BITE; INTERTRIGO; IRRITANT DERMATITIS; LICHEN PLANUS; LUPUS ERYTHEMATOSUS; NUMMULAR DERMATITIS; PAPULAR URTICARIA; PEMPHIGUS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SARCOIDOSIS; SEBORRHEIC DERMATITIS; SKIN ALLERGY; SKIN ATROPHY; SKIN DISEASE; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; TELANGIECTASIA; XEROSIS;

EID: 27944474291     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2005.06.010     Document Type: Review

References (36)

1. Strober B.E., Washenik K., and Shupack J.L. Principles of topical therapy Freedburg I.M. Eisen A.Z. Wolff K. 6th ed Fitzpatrick's Dermatology in General Medicine vol 2 2003 McGraw-Hill New York 2319 2323
2. Stoughton R.B. Percutaneous absorption of drugs Annu Rev Pharmacol Toxicol. 29 1989 55 69
3. Valencia I.C., and Kerdel F.A. Topical glucocorticoids Freedburg I.M. Eisen A.Z. Wolff K. 6th ed Fitzpatrick's Dermatology in General Medicine vol 2 2003 McGraw-Hill New York 2324 2328
4. Piacquadio D.J. Topical corticosteroids in clinical practice: Focus on fluticasone propionate Cutis 57 Suppl 2 1996 4 9
5. Stoughton R.B., and Wullich K. Relation of application time to bioactivity of a potent topical glucocorticoid formulation J Am Acad Dermatol. 22 1990 1038 1041
6. Stoughton R.B. The vasoconstrictor assay in bioequivalence testing: Practical concerns and recent developments Int J Dermatol. 31 Suppl 1 1992 26 28
7. Unpublished Galderma Laboratories LP. Study no. CG.03.SPR.4637 1997 Galderma Laboratories, LP Fort Worth, Tex
8. Decroix J., Pres H., and Tsankov N. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis Cutis 74 2004 201 206
9. Duweb G.A., Abuzariba O., and Rahim M. Scalp psoriasis: Topical calcipotriol 50 micrograms/g/mL solution vs. betamethasone valerate 1% lotion Int J Clin Pharmacol Res. 20 2000 65 68
10. James M. A randomized, double-blind, multicenter trial comparing fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, applied twice daily for 4 weeks in the treatment of psoriasis Cutis 67 Suppl 4 2001 2 9
11. Lassus A. Clinical comparison of alclometasone dipropionate cream 0.05% with hydrocortisone butyrate cream 0.1% in the treatment of atopic dermatitis in children J Int Med Res. 11 1983 315 319
12. Lassus A. Alclometasone dipropionate cream 0.05% versus clobetasone butyrate cream 0.05%. A controlled clinical comparison in the treatment of atopicdermatitis in children Int J Dermatol. 23 1984 565 566
13. Molin L., Cutler T.P., and Helander I. for the Calcipotriol Study Group Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study Br J Dermatol 136 1997 89 93
14. Yawalkar S.J., and Schwerzmann L. Double-blind, comparative clinical trials with halobetasol propionate cream in patients with atopic dermatitis J Am Acad Dermatol 25 1991 1163 1166
15. Bjornberg A., and Hellgren L. Double-blind double-bind Curr Med Res Opin. 3 1975 36 38
16. Kanof N.B., and Blau S. Psoriasis: Treatment with a new topical corticosteroid Cutis 17 1976 796 798
17. Bleehen S.S., Chu A.C., and Hamann I. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: A multicentre study comparing once-daily treatment and once-daily vehiclecream application versus twice-daily treatment Br J Dermatol 133 1995 592 597
18. van Dijk E., Bakkers E.J., and Go M.J. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream Cutis 32 1983 284 285
19. van Dijk E., Bakkers E.J., and Go M.J. Intermittent topical treatment of psoriasis with betamethasone dipropionate 0.05 percent cream Cutis 32 1983 287
20. Parish L.C., and Witkowski J.A. A comparison of betamethasone benzoate gel and betamethasone valerate cream Cutis 17 1976 972
21. Parish L.C., and Witkowski J.A. A comparison of betamethasone benzoate gel and betamethasone valerate cream Cutis 17 1976 984
22. Svartholm H., Larsson L., and Frederiksen B. Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate") Curr Med Res Opin. 8 1982 154 157
23. Pirozzi D.J. Evaluation of a new halcinonide formulation in the treatment of common dermatoses Cutis 30 1982 262 266
24. Afzelius H.W., and Jacobsen K.U. A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) inpsoriasis and other steroid-responsive dermatoses J Int Med Res. 7 1979 411 414
25. Viglioglia P., Jones M.L., and Peets E.A. Once-daily 0.1% mometasone furoate cream versus twice-daily 0.1% betamethasone valerate cream in the treatment of a variety of dermatoses J Int Med Res 18 1990 460 467
26. Freeman S., Howard A., and Foley P. Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis Australas J Dermatol 43 2002 186 189
27. Cabrera M.E. Treatment of severe or resistant corticosteroid-responsive dermatoses with Diprolene cream J Int Med Res. 12 1984 163 169
28. Lodolo J.C. Diprolene cream in the treatment of severe or resistant corticosteroidresponsive dermatoses J Int Med Res. 12 1984 114 120
29. Franz T.J., Parsell D.A., and Halualani R.M. Betamethasone valerate foam 0.12%: A novel vehicle with enhanced delivery and efficacy Int J Dermatol 38 1999 628 632
30. Internal study number RD.06.SRE.180001.R02 Breneman D., Fleischer A., and Foley V. Clobetasol propionate 0.05% is equivalent as lotion or emollient cream in atopic dermatitis Presented at the World Congress of Dermatology, 2002; and the European Academy of Dermatology and Venereology 2003
31. Unpublished Galderma Laboratories LP. Study no. CR.U.9707.R02 2000 Galderma Laboratories, LP Fort Worth, Tex
32. Stern R.S., Nijsten T., and Feldman S.R. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction J Investig Dermatol Symp Proc 9 2004 136 139
33. Housman T.S., Mellen B.G., and Rapp S.R. Patients with psoriasis prefer solution and foam vehicles: A quantitative assessment of vehicle preference Cutis 70 2002 327 332
34. Feldman S.R., and Housman T.S. Patients' vehicle preference for corticosteroid treatments of scalp psoriasis Am J Clin Dermatol 4 2003 221 224
35. Richards H.L., Fortune D.G., and O'Sullivan T.M. Patients with psoriasis and their compliance with medication J Am Acad Dermatol 41 1999 581 583
36. Williams H.C. Twice-weekly topical corticosteroid therapy may reduce atopic dermatitis relapses Arch Dermatol 140 2004 1151 1152